Holen Sie sich die Stockscreener-App
136.10
0.84%
1.13
Schlusskurs vom Vortag:
$134.97
Offen:
$135
24-Stunden-Volumen:
2.19M
Relative Volume:
0.58
Marktkapitalisierung:
$28.77B
Einnahmen:
$398.11M
Nettoeinkommen (Verlust:
$-1.03B
KGV:
-23.92
EPS:
-5.69
Netto-Cashflow:
$-868.57M
1W Leistung:
+3.20%
1M Leistung:
+29.62%
6M Leistung:
+72.17%
1J Leistung:
+78.30%
1-Tages-Spanne:
$134.39
$136.10
1-Wochen-Bereich:
$128.02
$136.90
52-Wochen-Spanne:
$60.40
$136.90
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
136.10 | 28.53B | 398.11M | -1.03B | -868.57M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
Signal strength of Insmed Incorporated stock in tech scanners2025 Price Targets & Smart Swing Trading Techniques - Newser
Analyzing Insmed Incorporated with risk reward ratio chartsJuly 2025 PreEarnings & Low Risk High Reward Ideas - Newser
What to do if you’re stuck in Insmed Incorporated2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Analyzing net buyer seller activity in Insmed IncorporatedTrade Analysis Report & Community Consensus Trade Signals - Newser
Is this a good reentry point in Insmed IncorporatedJuly 2025 Trade Ideas & Fast Gaining Stock Reports - Newser
Full technical analysis of Insmed Incorporated stock2025 Top Decliners & Weekly Return Optimization Plans - Newser
Should you wait for a breakout in Insmed IncorporatedJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
Intraday pattern recognizer results for Insmed IncorporatedMarket Sentiment Summary & Breakout Confirmation Trade Signals - Newser
Relative strength of Insmed Incorporated in sector analysisMarket Trend Report & Fast Exit Strategy with Risk Control - Newser
How sentiment analysis helps forecast Insmed IncorporatedWeekly Trend Report & Entry Point Strategy Guides - Newser
Insmed Gains 0.84% as $300M Volume Ranks 331st in Market Activity - AInvest
Custom watchlist performance reports with Insmed Incorporated2025 Market Outlook & Daily Profit Maximizing Trade Tips - Newser
Is Insmed Incorporated forming a reversal patternMarket Movement Recap & Expert Approved Momentum Ideas - Newser
What Fibonacci levels say about Insmed Incorporated reboundShare Buyback & Verified Momentum Stock Watchlist - Newser
Predicting Insmed Incorporated trend using moving averages2025 Historical Comparison & Verified Short-Term Plans - Newser
What high frequency data says about Insmed IncorporatedBreakout Watch & Precise Swing Trade Entry Alerts - Newser
Using AI based signals to follow Insmed IncorporatedJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Is Insmed Incorporated still worth holding after the dipMarket Performance Summary & AI Forecasted Entry and Exit Points - Newser
Exit strategy if you’re trapped in Insmed IncorporatedJuly 2025 Breakouts & Weekly High Return Opportunities - Newser
Is Insmed Incorporated stock entering bullish territoryMarket Performance Recap & Low Drawdown Investment Ideas - Newser
Has Insmed Incorporated found a price floor2025 Fundamental Recap & Technical Buy Zone Confirmation - Newser
Insmed Shares Soar 0.33% on $240M Volume (403rd) as FDA Approval and Strategic Deals Drive Growth - AInvest
Is it time to cut losses on Insmed IncorporatedJuly 2025 Institutional & Intraday High Probability Alerts - Newser
Insmed stock hits 52-week high at 136.42 USD - Investing.com
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Insmed Inc-Aktie (INSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Adsett Roger | Chief Operating Officer |
Aug 19 '25 |
Sale |
127.58 |
25,000 |
3,189,586 |
105,637 |
| Lewis William | Chair and CEO |
Aug 18 '25 |
Option Exercise |
10.85 |
6,865 |
74,485 |
240,789 |
| Lewis William | Chair and CEO |
Aug 18 '25 |
Sale |
128.40 |
6,865 |
881,470 |
233,924 |
1.89%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):